Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT02218060
Eligibility Criteria:
Inclusion Criteria:
* Subject must be between 18-90 years of age.
* Subject must have been referred for a clinically indicated cardiac catheterization or nuclear cardiac perfusion study.
* Subject must provide written informed consent prior to any study-related procedures being performed.
* Subject must be willing to comply with all clinical study procedures.
Exclusion Criteria:
* Subject is a pregnant or nursing female. Exclude the possibility of pregnancy:
* By testing (urine βHCG) within 24 hours before contrast agent administration, or
* By surgical sterilization, or
* Post menopausal, with minimum one (1) year history without menses.
* Subject has an acute psychiatric disorder or is cognitively impaired.
* Subject is using or is dependent on substances of abuse.
* Subject is unwilling to comply with the requirements of the protocol.
* Subject has decreased renal function (eGFR \<45)
* Subject has an allergy against iodinated contrast agents.
* Subject is in acute unstable condition.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT02218060
Study Brief:
Protocol Section:
NCT02218060